Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Advanced, Persistent, or Recurrent Endometrial Cancer × Medroxyprogesterone Acetate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Endometrial Neoplasms 4 Vitamin D Deficiency 1 Polycystic Ovary Syndrome 1 FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma 1 Endometrial Hyperplasia 1 Endometrial Adenocarcinoma 1 Carcinoma, Renal Cell 1 Breast Neoplasms 1 Advanced, Persistent, or Recurrent Endometrial Cancer 1 Adenocarcinoma 1

Interventions

Tamoxifen 1 Medroxyprogesterone Acetate 1 Letrozole 1 Everolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02228681 2024-09-19

Everolimus and Letrozole or Hormonal Therapy to Treat Endometrial Cancer

GOG Foundation

Phase 2 Completed

74 enrolled 13 charts

Advanced, Persistent, or Recurrent Endometrial Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡